345 related articles for article (PubMed ID: 36046821)
1. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells.
Fan Y; Cheng H; Liu Y; Liu S; Lowe S; Li Y; Bentley R; King B; Tuason JPW; Zhou Q; Sun C; Zhang H
Front Pharmacol; 2022; 13():955984. PubMed ID: 36046821
[No Abstract] [Full Text] [Related]
2. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT
Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674
[TBL] [Abstract][Full Text] [Related]
4. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
Feng TF; Yao DM; Zheng R; Jiang DS; Zhang LL; Xing Q; Li L
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):139-146. PubMed ID: 35184457
[No Abstract] [Full Text] [Related]
5. CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer.
Conley SJ; Baker TL; Burnett JP; Theisen RL; Lazarus D; Peters CG; Clouthier SG; Eliasof S; Wicha MS
Breast Cancer Res Treat; 2015 Apr; 150(3):559-67. PubMed ID: 25833208
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin Enhanced Anti-tumor Effects of Bevacizumab against Lung Adenocarcinoma A549 Cells
Tu X; Zhang J; Yuan W; Wu X; Xu Z; Qing C
Anticancer Agents Med Chem; 2023; 23(19):2083-2094. PubMed ID: 37587804
[TBL] [Abstract][Full Text] [Related]
7. Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.
Wu D; Wang J; Cai Y; Ren M; Zhang Y; Shi F; Zhao F; He X; Pan M; Yan C; Dou J
J Ovarian Res; 2015 Oct; 8():68. PubMed ID: 26497895
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition.
Chen D; Zhang Y; Wang J; Chen J; Yang C; Cai K; Wang X; Shi F; Dou J
J Ovarian Res; 2013 Jul; 6(1):50. PubMed ID: 23842108
[TBL] [Abstract][Full Text] [Related]
9. Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition.
Zhang L; Chen Y; Li F; Bao L; Liu W
Front Immunol; 2019; 10():867. PubMed ID: 31105696
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
[TBL] [Abstract][Full Text] [Related]
11. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival.
Cabuk D; Basaran G; Celikel C; Dane F; Yumuk PF; Iyikesici MS; Ekenel M; Turhal NS
Oncology; 2007; 72(1-2):111-7. PubMed ID: 18025805
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
15. AEG-1 Contributes to Metastasis in Hypoxia-Related Ovarian Cancer by Modulating the HIF-1alpha/NF-kappaB/VEGF Pathway.
Yu X; Wang Y; Qiu H; Song H; Feng D; Jiang Y; Deng S; Meng H; Geng J
Biomed Res Int; 2018; 2018():3145689. PubMed ID: 29770329
[TBL] [Abstract][Full Text] [Related]
16. HIF-1α siRNA and cisplatin in combination suppress tumor growth in a nude mice model of esophageal squamous cell carcinoma.
Liao HY; Wang GP; Gu LJ; Huang SH; Chen XL; Li Y; Cai SW
Asian Pac J Cancer Prev; 2012; 13(2):473-7. PubMed ID: 22524809
[TBL] [Abstract][Full Text] [Related]
17. Iridium nanozyme-mediated photoacoustic imaging-guided NIR-II photothermal therapy and tumor microenvironment regulation for targeted eradication of cancer stem cells.
Yao Y; Zhao Z; He J; Ali B; Wang M; Liao F; Zhuang J; Zheng Y; Guo W; Zhang DY
Acta Biomater; 2023 Dec; 172():369-381. PubMed ID: 37852456
[TBL] [Abstract][Full Text] [Related]
18. [Effect of HIF-2α on the biological characteristics of breast cancer stem cells].
Liu YQ; Li N; Huang HF; Li HX
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(4):269-273. PubMed ID: 29397612
[No Abstract] [Full Text] [Related]
19. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
20. [Effects of hypoxia-inducible factor 1α on hypoxic tolerance of human amniotic mesenchymal stem cells].
Ge L; Yu D; Su R; Cao Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 Mar; 32(3):264-269. PubMed ID: 29806273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]